For more than two decades ThermoGenesis Holdings, Inc. has developed and commercialized novel cell processing systems and devices providing global researchers, biomanufacturing organizations and clinicians with highly efficient cell processing devices which helped them to deliver better outcomes in various applications in the cell and gene therapy field.
We offer closed automated solutions for manual steps in the cell manufacturing process. Our flexible automated modules provide performance gains in purifying mononuclear cells, washing contaminants from cell fractions, cell selection, and storage while significantly shortening processing times.
When it comes to cell processing and cell manufacturing, it’s extremely important that samples are collected and stored properly so that they retain the greatest viability for use in the future. As you can imagine, there are some logistical challenges associated with cryopreserving samples at just the right temperature for an extended period of time, … Continued
Rob, currently a Technical Service Engineer, has been with ThermoGenesis for more than 30 years. He was drawn to the company in its initial stages, when it was still known as InstaCool and, after being hired on as a temp on the heels of his college graduation, joined the team as a Mechanical Engineer. Since … Continued
What is Cell Processing Cell processing is the practice of concentrating, selecting and/or culturing cells from blood or blood products, for example bone marrow or cord blood, that can then be used to treat diseases. The process begins with the collection of the blood or blood product (sample) from a person at a hospital or … Continued
Overview of Cord Blood and its Uses Cord blood is blood found in the blood vessels of the placenta and the umbilical cord. It is collected after a baby is born and once the umbilical cord is cut, making it a safe procedure for both mother and baby. Cord blood is a good source of … Continued
Cell and gene therapies have become increasingly popular in the last few decades, especially with the recent FDA approval of CAR T-cell therapies such as Kymriah and Yescarta. These life-changing therapies are the latest in scientific and technological advancements in the field of regenerative medicine and it is exciting to see the progress that has … Continued
Renee Ruecker, currently our Director of Accounting, has been with ThermoGenesis for over 20 years. She joined our team after spending a decade in public accounting, when she was looking to make a shift in her career. Renee wanted to be a part of a smaller company where she could really make an impact by … Continued